ReviewPharmaceutics2025

Role of Gut Microbiota and Metabolomics in Predicting Response to Vedolizumab in Inflammatory Bowel Disease: A Systematic Review.

Vaidota Malinauskiene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.